JP2006262863A - Method for evaluating external stimulation - Google Patents

Method for evaluating external stimulation Download PDF

Info

Publication number
JP2006262863A
JP2006262863A JP2005089667A JP2005089667A JP2006262863A JP 2006262863 A JP2006262863 A JP 2006262863A JP 2005089667 A JP2005089667 A JP 2005089667A JP 2005089667 A JP2005089667 A JP 2005089667A JP 2006262863 A JP2006262863 A JP 2006262863A
Authority
JP
Japan
Prior art keywords
yolk
blood vessel
state
blood
evaluation method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2005089667A
Other languages
Japanese (ja)
Inventor
Fumiaki Suzuki
文昭 鈴木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gifu University NUC
Original Assignee
Gifu University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gifu University NUC filed Critical Gifu University NUC
Priority to JP2005089667A priority Critical patent/JP2006262863A/en
Priority to PCT/JP2006/305687 priority patent/WO2006103988A1/en
Publication of JP2006262863A publication Critical patent/JP2006262863A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082Supracellular entities, e.g. tissue, organisms
    • G01N33/5088Supracellular entities, e.g. tissue, organisms of vertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a new method for evaluating external stimulation, which is useful for screening a candidate medicine. <P>SOLUTION: The method for evaluating external stimulation, in which the action of external stimulation is evaluated by using the state of a yolk cardiovascular system formed by at the initial stage of bird growth as an index, comprises (1) a step for preparing a fertilized egg of bird, (2) a step for providing the fertilized egg with external stimulation of a test object, (3) a step for assaying the state of the yolk cardiovascular system of the fertilized egg and (4) a step for evaluating the action of the external stimulation on the yolk cardiovascular system by the assayed result. <P>COPYRIGHT: (C)2007,JPO&INPIT

Description

本発明は、外部刺激の作用・影響をin vitroで評価する方法に関する。例えば薬剤候補の検索、又は薬剤の毒性や副作用の評価などに本発明の評価方法を利用できる。   The present invention relates to a method for evaluating the action and influence of external stimuli in vitro. For example, the evaluation method of the present invention can be used to search for drug candidates or to evaluate drug toxicity and side effects.

2000年には高血圧ガイドラインが引き下げられ、日本の高血圧患者は約3,700万人に上る。また、生活習慣病はその多くが血管病を併発し、悪化すれば致死性の疾患に陥る。代表的な致死性疾患の脳卒中では、動脈硬化を起こす前に薬物療法を施せば発症率が減るという報告がある。生活習慣病に伴う心臓病の治療薬として数種類が既に使われているが、世界中の患者数を考えるとより副作用の少ない効果的な治療薬の開発が急がれる。
新薬の開発において未だに多くの労力と時間を必要としている部分が、薬剤候補の有効性と有害性を実験的に見極めるスクリーニング及び臨床の段階であるといわれている。そのスクリーニング作業のコストを大幅に削減し、より多くの薬剤候補の可能性についてより詳細に検討できるスクリーニングシステムを開発することは新薬開発の競争力を向上させることになる。
尚、薬剤のスクリーニング方法の一例が特許公報1に開示されている。
In 2000, the guidelines for hypertension were lowered, and there are about 37 million people with hypertension in Japan. Many lifestyle-related diseases are accompanied by vascular disease, and if they worsen, they become fatal diseases. In strokes of typical fatal diseases, there is a report that the incidence decreases if pharmacotherapy is given before arteriosclerosis occurs. Several types of treatments for heart disease associated with lifestyle-related diseases have already been used, but considering the number of patients around the world, the development of effective treatments with fewer side effects is urgent.
It is said that the part that still requires a lot of labor and time in the development of new drugs is the screening and clinical stage to experimentally determine the effectiveness and harmfulness of drug candidates. Developing a screening system that can greatly reduce the cost of the screening work and examine the potential of more drug candidates in more detail will improve the competitiveness of new drug development.
An example of a drug screening method is disclosed in Patent Publication 1.

特表平9−509829号公報Japanese National Patent Publication No. 9-509829

現状の薬剤開発においては、培養細胞などを用いたin vitroスクリーニングの後、マウス、ラット、ウサギなどの実験動物を用いたin vivo検証を実施するのが通常の手順である。マウスなどの哺乳類は小さく取り扱いが容易であるが、同一条件で複数のサンプルを扱うためには大掛かりな設備が必要となる。さらに、実験動物の安定供給や飼育コストなどの問題も大きい。
一方、入手が容易なニワトリの卵を利用したスクリーニング系が提案されている。即ち、尿漿膜血管系を利用して血管新生の定量を行うことによって、血管新生に作用する物質をスクリーニングする試みが報告されている。尿漿膜血管系は、胚の発生ステージ18頃に発生し、比較的孔径の大きい血管を軸とした安定した血管網を形成する。このように血管が比較的太く、また安定していることから、尿漿膜血管系は状態変化を観察する目的に適したものと考えられてきた。しかしながら尿漿膜血管系では卵の表層近くだけでなく内部へも多くの血管が伸展するため実際は観察し難く、血管の数や量などを正確に把握することが困難である。また、尿漿膜血管系が形成される発生段階では胚が活発に動くことから、胚の動きに伴う血管の揺れや移動を考慮した測定が必要となる。従って測定が困難となり、また得られるデータの信頼性も低い。
In the current drug development, it is a normal procedure to conduct in vivo verification using experimental animals such as mice, rats, and rabbits after in vitro screening using cultured cells. Mammals such as mice are small and easy to handle, but large facilities are required to handle multiple samples under the same conditions. In addition, problems such as stable supply of laboratory animals and breeding costs are also significant.
On the other hand, screening systems using chicken eggs that are easily available have been proposed. That is, attempts have been reported to screen for substances that act on angiogenesis by quantifying angiogenesis using the serous vasculature. The serous vasculature develops around the embryonic development stage 18 and forms a stable vascular network centered on a blood vessel having a relatively large pore diameter. Since the blood vessels are relatively thick and stable as described above, the serous vasculature has been considered suitable for the purpose of observing the state change. However, in the serous vasculature, many blood vessels extend not only near the surface of the egg but also inside, so that it is difficult to actually observe, and it is difficult to accurately grasp the number and amount of blood vessels. In addition, since the embryo moves actively at the developmental stage where the serous vasculature is formed, it is necessary to take into account the fluctuation and movement of blood vessels accompanying the movement of the embryo. Therefore, measurement becomes difficult and the reliability of the obtained data is low.

一方、血管新生の評価方法としてウサギ網膜血管系を利用した方法や、培養細胞レベルでの血管形成を指標とした方法なども過去に提案されているが、血管の数の増減若しくは血管の太さ又は血球の流れていない管のみの極微形成面積の変移過程を撮影及び解析するのみであり、真の血管新生の定量的観察法は確立されていない。また、特にウサギ網膜血管系を利用した方法では血管の観察も困難であるという問題が付随する。   On the other hand, methods using the retinal vasculature of rabbits as a method for evaluating angiogenesis and methods using blood vessel formation at the level of cultured cells as an index have been proposed in the past. Alternatively, only the imaging and analysis of the transition process of the microscopic area of only the tube in which no blood cells flow is performed, and a quantitative observation method of true angiogenesis has not been established. In addition, the method using the rabbit retinal vasculature is accompanied by the problem that it is difficult to observe blood vessels.

以上の背景の下、本発明者らは薬剤候補の検索や評価などに利用できる新たな評価系の構築を目指して鋭意検討した。その結果、鳥類の卵の発生初期に形成される卵黄血管系を利用すれば、血管新生の定量的観察が容易であることをはじめ、以下に示す多くの利点を有する評価系(測定系)を構築できるとの知見を得た。
(1)卵黄血管系は感受性が高く、外部刺激を与えたときの応答性に優れる。また、卵黄血管系では血管新生、血管の伸長、及び血管の肥大が盛んである。これらの特徴によって迅速な評価が可能となる。また、微量の試料での測定・評価が可能となる。このことは例えば、大量に調製することが困難な物質の作用を評価する場合に特に有効な評価系になることを意味する。
(2)卵黄血管系は発生段階ではじめに形成される血管系であり、しかも卵の表層近くに形成されることからその観察及び測定が容易である。また、単純な構造であることも、卵黄血管系の観察及び測定に対して有利に働く。
(3)動物個体に比較して鳥類の卵は個体差が小さいことから、得られるデータの信頼性が高く、再現性もよい。
(4)同じ個体(卵)で経時的な観察・測定が可能である。
(5)卵黄血管系の形成時期は胚がほぼ静止した状態である。従って、胚の動きに伴う血管の揺れや移動がほとんどなく、血管の観察・測定が容易且つ高精度に行える。尚、尿漿膜血管系の形成時期では胚の動きが活発であり、血管の揺れ等が激しい。
(6)例えばニワトリの卵などを用いれば安定供給が比較的容易であり、飼育コスト面でも有利である。
(7)卵黄血管の形成時期の卵では心臓の拍動も肉眼で確認できる。また毛細血管を流れる血球を観察することも可能である。
(8)以上の多くの利点から、鳥類の卵黄血管系を利用した評価系は、測定の自動化が容易であり、高速なスクリーニングシステムを実現するのに最適な系といえる。
Under the above background, the present inventors have intensively studied with the aim of constructing a new evaluation system that can be used for searching and evaluating drug candidates. As a result, using the yolk vasculature formed early in the development of avian eggs, it is easy to quantitatively observe angiogenesis, and the evaluation system (measurement system) has many advantages shown below. The knowledge that it can build was obtained.
(1) The yolk vasculature is highly sensitive and has excellent responsiveness when given external stimuli. In addition, in the yolk vasculature, angiogenesis, blood vessel elongation, and blood vessel hypertrophy are prosperous. These features enable rapid evaluation. In addition, measurement and evaluation with a very small amount of sample is possible. This means, for example, that the evaluation system is particularly effective when evaluating the action of substances that are difficult to prepare in large quantities.
(2) The yolk vasculature is a vasculature that is first formed at the developmental stage and is formed near the surface of the egg, so that observation and measurement are easy. The simple structure is also advantageous for observation and measurement of the yolk vasculature.
(3) Bird eggs have small individual differences compared to individual animals, so the data obtained is highly reliable and reproducible.
(4) The same individual (egg) can be observed and measured over time.
(5) The formation time of the yolk vasculature is that the embryo is almost stationary. Therefore, there is almost no shaking or movement of blood vessels accompanying the movement of the embryo, and blood vessel observation and measurement can be performed easily and with high accuracy. In addition, the movement of the embryo is active at the time of formation of the urinary serosa vasculature, and the shaking of the blood vessel is intense.
(6) For example, if chicken eggs are used, stable supply is relatively easy, which is advantageous in terms of breeding costs.
(7) In the egg at the time of yolk blood vessel formation, the pulsation of the heart can also be confirmed with the naked eye. It is also possible to observe blood cells flowing through capillaries.
(8) Because of the many advantages described above, the evaluation system using the avian egg yolk vasculature is easy to automate the measurement and can be said to be the optimal system for realizing a high-speed screening system.

本発明は以上の成果及び知見に基づき、以下のステップを含んで構成される、外部刺激の作用を評価する方法を提供する。
(1)鳥類の受精卵を用意するステップ、
(2)前記受精卵に対して被験対象の外部刺激を与えるステップ、
(3)前記受精卵の卵黄心血管系の状態を測定するステップ、
(4)測定結果より、前記外部刺激の卵黄心血管系への作用を評価するステップ。
The present invention provides a method for evaluating the action of an external stimulus, which includes the following steps based on the above results and knowledge.
(1) a step of preparing a fertilized egg of a bird,
(2) applying an external stimulus of a test subject to the fertilized egg,
(3) measuring the state of the yolk cardiovascular system of the fertilized egg,
(4) A step of evaluating the effect of the external stimulus on the yolk cardiovascular system from the measurement result.

本発明の一態様では受精卵が胚の発生ステージ15〜22のときにステップ(2)を実施する。更に好ましくは受精卵が胚の発生ステージ15〜18のときにステップ(2)を実施する。更に更に好ましくは受精卵が胚の発生ステージ17〜18のときにステップ(2)を実施する。外部刺激を与える時期が早すぎると胚が損傷を受け、卵黄血管系の形成に影響を及ぼし、卵黄血管系の状態を指標として評価することが困難となるからである。
一方、尿漿膜血管系が卵黄血管系よりも優勢になる前にステップ(3)を実施することが好ましい。尿漿膜血管系が優勢になると卵黄血管の状態又は胚の状態を観察し難くなるからである。例えば、受精卵が胚の発生ステージ17〜22のときにステップ(3)を実施することが好ましい。
In one aspect of the present invention, step (2) is performed when the fertilized egg is in the embryonic development stage 15-22. More preferably, step (2) is performed when the fertilized egg is in the embryonic development stage 15-18. Even more preferably, step (2) is performed when the fertilized egg is in the embryonic development stage 17-18. This is because if the timing of external stimulation is too early, the embryo is damaged and affects the formation of the yolk vasculature, making it difficult to evaluate the state of the yolk vasculature as an index.
On the other hand, it is preferable to perform step (3) before the serous vasculature becomes dominant over the yolk vasculature. This is because when the serous vasculature becomes dominant, it becomes difficult to observe the state of the yolk blood vessel or the state of the embryo. For example, step (3) is preferably performed when the fertilized egg is in the embryonic development stage 17-22.

本発明の一態様ではステップ(3)において卵黄心血管系の状態を経時的に測定する。これによって、外部刺激が卵黄心血管系に及ぼす作用・影響の経時的変化を評価できる。   In one embodiment of the present invention, the state of the yolk cardiovascular system is measured over time in step (3). As a result, it is possible to evaluate changes over time in the action and influence of external stimuli on the yolk cardiovascular system.

被験対象となる外部刺激は例えば、被験物質の添加、光の照射、電磁波の照射、放射線の照射、音波の照射、電気刺激、振動の付加、及び圧力の付加からなる群より選択される一以上の外部刺激である。
一方、卵黄心血管系の状態は例えば、血管の面積、血管の数、血管の幅又は径、血管の枝分かれの状態、血管の伸長速度、血液量、血液の流速、血球移動速度、及び胚の心拍数からなる群より選択される一以上の項目である。本発明の好ましい一態様では血管の面積、血管の数、血管の幅又は径、血管の枝分かれの状態、及び血管の伸長速度からなる群より選択される一以上を測定項目とする。
鳥類の種類として好ましくはニワトリ又はウズラが選択される。これらの受精卵は比較的入手が容易だからである。
The external stimulus to be tested is, for example, one or more selected from the group consisting of test substance addition, light irradiation, electromagnetic wave irradiation, radiation irradiation, sound wave irradiation, electrical stimulation, vibration addition, and pressure addition Is an external stimulus.
On the other hand, the state of the yolk heart vasculature is, for example, the area of the blood vessel, the number of blood vessels, the width or diameter of the blood vessel, the state of branching of the blood vessel, the blood vessel elongation rate, the blood volume, the blood flow rate, the blood cell migration rate, One or more items selected from the group consisting of heart rate. In a preferred embodiment of the present invention, the measurement item is one or more selected from the group consisting of the area of the blood vessel, the number of blood vessels, the width or diameter of the blood vessel, the state of branching of the blood vessel, and the blood vessel elongation rate.
A chicken or quail is preferably selected as the type of bird. This is because these fertilized eggs are relatively easy to obtain.

(用語)
本明細書では、卵黄血管と、卵黄血管形成時期の心臓とを包括的に表現する用語として「卵黄心血管系」を用いる。従って、本明細書において「卵黄心血管系の状態」には、卵黄血管の状態と、卵黄血管形成時期の心臓の状態(例えば心拍数)とが含まれる。
(the term)
In this specification, “yolk cardiovascular system” is used as a term that comprehensively expresses yolk blood vessels and the heart at the time of yolk blood vessel formation. Therefore, in this specification, the “state of the yolk cardiovascular system” includes the state of the yolk blood vessel and the state of the heart at the time of yolk blood vessel formation (for example, the heart rate).

本発明は外部刺激の作用を評価する方法に関する。本発明による評価結果に基づいて、細胞又は生体に対して有効な外部刺激をスクリーニングすることができる。また、ある外部刺激が細胞に及ぼす悪影響(例えば毒性、副作用)の程度を評価することにも本発明を利用できる。
本明細書において「外部刺激」とは(1)薬剤候補など被験物質の添加、(2)光、電磁波、放射線、音波などの照射、(3)電気刺激、(4)振動、及び(5)圧力の付加などである。
The present invention relates to a method for evaluating the action of an external stimulus. Based on the evaluation result according to the present invention, it is possible to screen an external stimulus effective for a cell or a living body. The present invention can also be used to evaluate the degree of adverse effects (for example, toxicity and side effects) that an external stimulus has on cells.
As used herein, `` external stimulation '' refers to (1) addition of test substances such as drug candidates, (2) irradiation with light, electromagnetic waves, radiation, sound waves, (3) electrical stimulation, (4) vibration, and (5) Such as the addition of pressure.

本発明の評価方法は次の各ステップを含む。
(1)鳥類の受精卵を用意するステップ。
(2)前記受精卵に対して被験対象の外部刺激を与えるステップ。
(3)前記受精卵の卵黄心血管系の状態を測定するステップ。
(4)測定結果より、前記外部刺激の卵黄心血管系への作用を評価するステップ。
以下、各ステップについて詳細に説明する。
The evaluation method of the present invention includes the following steps.
(1) A step of preparing fertilized eggs for birds.
(2) A step of applying an external stimulus to the test subject to the fertilized egg.
(3) A step of measuring the state of the yolk cardiovascular system of the fertilized egg.
(4) A step of evaluating the effect of the external stimulus on the yolk cardiovascular system from the measurement result.
Hereinafter, each step will be described in detail.

1.ステップ(1)
ステップ(1)では鳥類の受精卵を用意する。ここでの鳥類は例えばニワトリ、ウズラ、七面鳥、アヒル、ガチョウ、ダチョウ、チャボ、鳩である。ニワトリ又はウズラの受精卵を用いることが好ましい。受精卵の入手が比較的容易だからである。ニワトリの受精卵を用いることが最も好ましい。受精卵の供給及び流通の体制が最も整っているからである。また、ウズラに比較して卵が大きいため取り扱い易く、卵黄心血管系の観察・測定も容易だからである。
1. step 1)
In step (1), fertilized eggs of birds are prepared. Birds here are, for example, chickens, quails, turkeys, ducks, geese, ostriches, teabos and pigeons. Preferably, chicken or quail fertilized eggs are used. This is because it is relatively easy to obtain a fertilized egg. Most preferably, chicken fertilized eggs are used. This is because the fertilized egg supply and distribution system is the most complete. In addition, the egg is larger than the quail, so it is easy to handle and the yolk cardiovascular system is easy to observe and measure.

後述のように本発明の評価方法では、卵黄心血管系の状態を観察・測定対象とする。従って、後に卵黄心血管系の観察・測定が可能な状態の受精卵を用意する必要がある。好ましくは尿漿膜血管系形成開始前の受精卵を使用する。
ニワトリの卵では通常、胚の発生ステージ15頃(受精後約2日)に卵黄血管が発生し始め、発生ステージ17頃(受精後約2日〜3日)には肉眼で容易に観察される程度に血管網を形成する。そして、発生ステージ22〜24頃(受精後約3〜4日)に卵黄血管の一部が消失し始め、発生ステージ30頃(受精後約7日〜8日)には卵黄血管のほぼ完全な消失に至る。一方、尿漿膜血管は通常、胚の発生ステージ18頃(受精後約3日)に発生し始める。従って、ニワトリの卵を用いる場合には通常、胚の発生ステージ28前、好ましくは胚の発生ステージ22前、更に好ましくは胚の発生ステージ17前、更に更に好ましくは胚の発生ステージ15前の段階にある受精卵を用意する。このように比較的発生初期の段階にある受精卵を使用することによって、タイミングよく且つ十分な時間的余裕をもって、更には尿漿膜血管の影響の少ない状態で、後述の外部刺激の付加及びその後の測定を実施することができる。
ニワトリ以外の鳥類の卵を用いる場合にも、上記の発生ステージと同等の発生ステージの受精卵が用いられる。
尚、ニワトリ胚の発生段階は、Hamburger V. and Hamilton H.L.(1951) J. Morphol. 88: 49-92に準ずる(「発生生物学の必須テクニック(Essential Developmetal Biology, A Practical Approach,ed. C.C. Stein & P.W.H. Holland)」八杉貞夫監修、メディカル・サイエンス・インターナショナル社を参照)。
As will be described later, in the evaluation method of the present invention, the state of the yolk cardiovascular system is the object of observation / measurement. Therefore, it is necessary to prepare a fertilized egg in a state in which the yolk cardiovascular system can be observed and measured later. Preferably, a fertilized egg before the start of urinary serous vasculature formation is used.
In chicken eggs, egg yolk blood vessels usually begin to develop around the embryonic development stage 15 (about 2 days after fertilization) and are easily observed with the naked eye around the developmental stage 17 (about 2 to 3 days after fertilization). Form a vascular network to the extent. Then, some of the yolk blood vessels begin to disappear around the development stage 22 to 24 (about 3 to 4 days after fertilization), and the yolk blood vessels are almost completely around the development stage 30 (about 7 to 8 days after fertilization). It will disappear. On the other hand, urinary serosa blood vessels usually begin to develop around embryonic development stage 18 (about 3 days after fertilization). Therefore, in the case of using chicken eggs, the stage is usually before the embryo development stage 28, preferably before the embryo development stage 22, more preferably before the embryo development stage 17, and even more preferably before the embryo development stage 15. Prepare a fertilized egg. By using a fertilized egg in a relatively early stage of development in this way, with the addition of an external stimulus described later and the subsequent time in a timely and sufficient time margin and with little influence of serous blood vessels. Measurements can be performed.
When using eggs from birds other than chickens, fertilized eggs at the same generation stage as described above are used.
The developmental stage of the chicken embryo is in accordance with Hamburger V. and Hamilton HL (1951) J. Morphol. 88: 49-92 (“Essential Developmetal Biology, A Practical Approach, ed. CC Stein & PWH Holland), supervised by Sadao Yasugi, see Medical Science International.

発生を促すために受精卵は転卵培養される。例えば約37℃、相対湿度約60%に調整した恒温槽内で1時間に1〜2回、転卵する(90°)条件下で転卵培養する。   In order to promote development, fertilized eggs are tumbled. For example, the eggs are cultured in a thermostat adjusted to about 37 ° C. and a relative humidity of about 60% under the condition of turning eggs (90 °) once or twice per hour.

2.ステップ(2)
ステップ(2)では、用意した受精卵に外部刺激を与える。即ち、このステップでは被験対象の外部刺激が受精卵に加えられる。上記の通り、本発明における外部刺激は(1)薬剤候補など被験物質の添加、(2)光、電磁波、放射線、音波などの照射、(3)電気刺激、(4)振動の付加、及び(5)圧力の付加などである。
本発明の好ましい一態様では被験物質の添加による外部刺激を受精卵に与える。この態様の評価方法では被験物質の作用が評価されることになる。このような評価系は薬剤候補の検索や薬剤の毒性・副作用の評価に有効である。特に、ある物質の血管系に対する作用(影響)を評価するために本発明の方法を好適に利用できる。具体的には、血管系に作用する化合物(血管新生を阻害又は促進する化合物。例えば抗癌剤の候補)のスクリーニングに本発明を利用することができる。
2. Step (2)
In step (2), an external stimulus is applied to the prepared fertilized egg. That is, in this step, the external stimulus of the test subject is applied to the fertilized egg. As described above, external stimuli in the present invention include (1) addition of test substances such as drug candidates, (2) irradiation with light, electromagnetic waves, radiation, sound waves, (3) electrical stimulation, (4) addition of vibration, and ( 5) Adding pressure.
In a preferred embodiment of the present invention, an external stimulus by adding a test substance is given to a fertilized egg. In the evaluation method of this aspect, the action of the test substance is evaluated. Such an evaluation system is effective for searching for drug candidates and evaluating the toxicity and side effects of drugs. In particular, the method of the present invention can be suitably used for evaluating the action (influence) of a substance on the vascular system. Specifically, the present invention can be used for screening for compounds that act on the vascular system (compounds that inhibit or promote angiogenesis; for example, candidates for anticancer agents).

二つ以上の外部刺激を組み合わせて与えることにしてもよい。例えば被験物質の添加と光照射の併用、被験物質の添加と電気刺激の併用などである。かかる態様によれば、種類の異なる外部刺激を組み合わせたときの血管系に対する作用を評価できる。例えば、ある薬剤の添加と電気刺激とを併用したことによって薬効が増強されるとの結果が得られれば、電気刺激を与えながら当該薬剤を投与することが高い治療効果の発揮に有効であると判断することができる。
同種の外部刺激を組み合わせて与えることにしてもよい。例えば、二つ以上の被験物質を同時に添加する場合がこれに該当する。ここでの「同時」は時間的に厳密な同時性を意味するのではなく、二つ以上の被験物質の添加が間隔を置いて行われても良い。
Two or more external stimuli may be given in combination. For example, the combined use of test substance and light irradiation, the combined use of test substance and electrical stimulation, and the like. According to this aspect, it is possible to evaluate the action on the vascular system when different types of external stimuli are combined. For example, if it is obtained that the efficacy is enhanced by the combined use of a certain drug and electrical stimulation, administration of the drug while applying electrical stimulation is effective for exerting a high therapeutic effect. Judgment can be made.
A combination of external stimuli of the same kind may be given. For example, this is the case when two or more test substances are added simultaneously. Here, “simultaneous” does not mean exact synchronicity in time, but two or more test substances may be added at intervals.

典型的には、予め卵殻の一部を除去して卵の内部を観察できる状態にした後に外部刺激を加える。卵殻の一部の除去は例えば次の手順で行う。
(1)受精卵の卵殻鈍端部(気質側)を上にする。
(2)殻の一部に孔をあけ、この孔を利用して卵白を少量(例えば約15ml)抜きとる。これによって、卵の液面が下がる。
(3)卵の液面の若干上の位置で卵殻を切断し、殻の鈍端部(気質側)を取り除く。尚、卵殻の一部を除去した後は、転卵培養から静置培養に切り替える。
Typically, an external stimulus is applied after a portion of the eggshell has been previously removed so that the inside of the egg can be observed. The removal of part of the eggshell is performed, for example, by the following procedure.
(1) With the blunt end (temperament side) of the fertilized egg up.
(2) A hole is made in a part of the shell, and a small amount (eg, about 15 ml) of egg white is extracted using this hole. This lowers the egg liquid level.
(3) Cut the eggshell slightly above the egg liquid level and remove the blunt end (temperament side) of the shell. In addition, after removing a part of eggshell, it switches from egg-turn culture to stationary culture.

卵の一部又は全体に対して外部刺激が与えられる。外部刺激として被験物質の添加を行う態様では、以下の手順で卵の一部に外部刺激を与えることができる。
(1)卵殻の一部を除去することで露呈した卵の表面に、一部が開口した小板(例えばドーナツ状の小板)を載せる。
(2)小板の開口部を介して被験物質を卵表面に添加する。これによって、卵表面において小板の開口部に対応する部分のみが被験物質に直接曝露される。
An external stimulus is applied to part or all of the egg. In the embodiment in which the test substance is added as an external stimulus, the external stimulus can be applied to a part of the egg by the following procedure.
(1) A small plate (for example, a donut-shaped small plate) partially opened is placed on the surface of an egg exposed by removing a part of the eggshell.
(2) The test substance is added to the egg surface through the opening of the platelet. Thereby, only the part corresponding to the opening of the platelet on the egg surface is directly exposed to the test substance.

外部刺激を与える前又は測定(ステップ(3))の前に殻から卵を取り出し、別容器に移すことにしてもよい。但し、操作が煩雑となること、胚を測定に好ましい位置にするのが困難なこと等の理由から、操作の全過程を通して卵を卵殻内に維持することが好ましい。   The egg may be removed from the shell and transferred to a separate container before applying an external stimulus or before measurement (step (3)). However, it is preferable to maintain the eggs in the eggshell throughout the entire operation because of complicated operations and difficulty in placing the embryo in a preferred position for measurement.

本発明の評価方法では卵黄心血管系の状態を指標として外部刺激の作用を評価する。従って卵黄心血管系が形成される前又は卵黄心血管系の形成段階で外部刺激を与える。好ましくは外部刺激を与える時期を、胚が形態的に完成された段階(ニワトリ胚では発生ステージ15〜16)以降とする。これによって胚への外部刺激の影響が低減され、卵黄血管を比較的長期に亘って観察することが可能となる(外部刺激を与える時期が早すぎると胚が損傷を受け、卵黄心血管系の形成に影響を及ぼし、長期的な観察が困難となる)。一方、上記の通り卵黄心血管系は短期間で消失する運命にあることから、卵黄心血管系の状態を指標として外部刺激の作用を評価するためには卵黄血管系が形成される前の時期、又は卵黄血管系の形成段階のできるだけ早い時期に外部刺激を与えることが好ましいといえる。以上の事情を考慮すれば、ニワトリの卵を用いる場合、本発明における外部刺激を与える時期は例えば胚の発生ステージ15〜28(受精後約2日〜6日)、好ましくは胚の発生ステージ15〜22(受精後約2日〜4日)、更に好ましくは胚の発生ステージ15〜18(受精後約2日〜3日)、更に更に好ましくは胚の発生ステージ17〜18(受精後約2日〜3日)である。   In the evaluation method of the present invention, the effect of external stimulation is evaluated using the state of the yolk cardiovascular system as an index. Accordingly, external stimulation is applied before the yolk cardiovascular system is formed or at the stage of yolk cardiovascular system formation. Preferably, the external stimulus is applied after the stage when the embryo is morphologically completed (development stages 15 to 16 for chicken embryos). This reduces the effects of external stimuli on the embryo and makes it possible to observe the yolk blood vessels over a relatively long period of time (if the external stimulus is applied too early, the embryo is damaged and the yolk cardiovascular system is damaged. Affects the formation and makes long-term observation difficult). On the other hand, as described above, the yolk cardiovascular system is destined to disappear in a short period of time. Alternatively, it may be preferable to apply an external stimulus as early as possible in the stage of formation of the yolk vasculature. In consideration of the above circumstances, when a chicken egg is used, the timing for applying an external stimulus in the present invention is, for example, embryo development stage 15 to 28 (about 2 to 6 days after fertilization), preferably embryo development stage 15 ~ 22 (about 2 to 4 days after fertilization), more preferably embryo development stage 15 to 18 (about 2 to 3 days after fertilization), still more preferably embryo development stage 17 to 18 (about 2 after fertilization) Days to 3 days).

3.ステップ(3)
ステップ(3)では、外部刺激を与えた後の受精卵において卵黄心血管系の状態を測定する。卵黄血管の形成開始時から卵黄血管が消失するまでの間に測定が実施される。ここで、卵黄血管が形成される段階の卵は透明性が高く、胚の状態を外部から把握することが容易である。また、この段階の胚はほとんど静止した状態であることから観察し易い。従って、卵黄血管が形成される時期に測定を実施することによって、血管の状態のみならず胚の状態(例えば心臓の拍動)をも良好な条件で観察し、評価することが可能となる。
上記の通り、ニワトリの卵では通常、胚の発生ステージ15頃(受精後約2日)に卵黄血管が発生し始め、発生ステージ17頃(受精後約2日〜3日)には肉眼で容易に観察される程度に血管網を形成する。そして、発生ステージ22〜24頃(受精後約3〜4日)に卵黄血管の一部が消失し始め、発生ステージ30頃(受精後約7日〜8日)には卵黄血管のほぼ完全な消失に至る。一方、尿漿膜血管は通常、胚の発生ステージ18頃(受精後約3日)に発生し始め、発生ステージ23頃(受精後約4日)には肉眼で観察できる程度となり、発生ステージ28頃(受精後約6日目)には卵黄血管よりも優勢となる。尿漿膜血管が優勢になると、尿漿膜血管が障害となって卵黄心血管系の状態を観察し難くなることから、尿漿膜血管が優勢になる前の段階に測定することが好ましい。
以上の卵黄血管及び尿漿膜血管の形成時期を考慮すれば、ニワトリ卵を用いる場合の本発明における測定時期は、例えば胚の発生ステージの15〜30(受精後約2日〜8日)であり、好ましくは胚の発生ステージ15〜27(受精後約2日〜5日)であり、更に好ましくは胚の発生ステージ17〜27(受精後約3日〜5日)であり、更に更に好ましくは胚の発生ステージ17〜22(受精後約3日〜4日)である。胚の発生ステージ17〜22では、肉眼でも観察できる程度に卵黄血管が形成されており、しかも尿漿膜血管はほとんど認められないことから、卵黄心血管系の状態を容易且つ良好に観察・測定可能である。
尚、ニワトリ以外の鳥類の卵を用いる場合にも、上記の発生ステージと同等の発生ステージに測定を実施することが好ましい。
3. Step (3)
In step (3), the state of the yolk cardiovascular system is measured in the fertilized egg after applying the external stimulus. The measurement is performed from the start of yolk blood vessel formation to the disappearance of the yolk blood vessel. Here, the egg at the stage where the yolk blood vessel is formed is highly transparent, and it is easy to grasp the state of the embryo from the outside. In addition, the embryo at this stage is easy to observe because it is almost stationary. Therefore, by performing the measurement at the time when the yolk blood vessel is formed, it is possible to observe and evaluate not only the state of the blood vessel but also the state of the embryo (for example, the pulsation of the heart) under good conditions.
As described above, egg yolk blood vessels usually begin to develop around the embryonic development stage 15 (about 2 days after fertilization) in the chicken egg, and easily with the naked eye around the developmental stage 17 (about 2 to 3 days after fertilization). A blood vessel network is formed to the extent observed in Then, some of the yolk blood vessels begin to disappear around the development stage 22 to 24 (about 3 to 4 days after fertilization), and the yolk blood vessels are almost completely around the development stage 30 (about 7 to 8 days after fertilization). It will disappear. On the other hand, urinary serosa blood vessels usually begin to develop around the embryonic development stage 18 (about 3 days after fertilization) and become visible to the naked eye around the developmental stage 23 (about 4 days after fertilization). It becomes more dominant than yolk blood vessels (about 6 days after fertilization). When the serous blood vessel becomes dominant, it becomes difficult to observe the state of the egg yolk cardiovascular system because the serous blood vessel becomes obstructed. Therefore, measurement is preferably performed before the serous blood vessel becomes dominant.
Considering the above-mentioned formation time of yolk blood vessel and urinary serosa blood vessel, the measurement time in the present invention when using a chicken egg is, for example, 15 to 30 (about 2 to 8 days after fertilization) at the embryonic development stage. Embryo development stage 15 to 27 (about 2 to 5 days after fertilization), more preferably embryo development stage 17 to 27 (about 3 to 5 days after fertilization), still more preferably Embryo development stages 17-22 (about 3-4 days after fertilization). In the embryonic development stages 17 to 22, the yolk blood vessels are formed to such an extent that they can be observed with the naked eye, and the serous blood vessels are hardly observed, so that the state of the yolk cardiovascular system can be observed and measured easily and satisfactorily. It is.
In addition, even when using eggs of birds other than chickens, it is preferable to carry out the measurement at a generation stage equivalent to the above-described generation stage.

本発明では卵黄心血管系の状態、即ち卵黄血管の状態及び/又は卵黄血管形成時期の心臓の状態が測定対象となる。具体的には「卵黄心血管系の状態」は、卵黄血管形成時期の血管の面積(例えば、測定領域における総面積)、血管の数(例えば、測定領域における総数)、血管の幅又は径(例えば、注目する血管のもの、又は測定領域における平均)、血管の枝分かれの状態(例えば、注目する血管のもの、又は測定領域における枝分かれの総数や総血管長)、血管の伸長速度、血液量、血液の流速、血球移動速度、及び胚の心拍数を含む。従って本発明では、以上の中から選択される一つ以上が測定項目となる。
これらの中でも血管の面積、血管の数、血管の 血管の幅又は径、血管の枝分かれの状態、及び血管の伸長速度は測定が容易であり、また血管新生の状態を把握するための指標として特に有効であると考えられる。従って本発明の好ましい一態様では測定項目つとして血管の数、血管の面積、血管の幅又は径、血管の枝分かれの状態、及び/又は血管の伸長速度が採用される。
本発明の特に好ましい一態様では測定項目の一つとして血管の総面積が採用される。
In the present invention, the state of the yolk cardiovascular system, that is, the state of the yolk blood vessel and / or the state of the heart at the time of yolk blood vessel formation is the measurement object. Specifically, “the yolk heart vascular system state” includes the area of blood vessels at the time of yolk blood vessel formation (for example, the total area in the measurement region), the number of blood vessels (for example, the total number in the measurement region), the width or diameter of the blood vessels ( For example, that of the target blood vessel or the average in the measurement region), the state of branching of the blood vessel (for example, that of the target blood vessel, or the total number of branches in the measurement region or the total blood vessel length), the blood vessel extension rate, the blood volume, Includes blood flow rate, blood cell migration rate, and embryo heart rate. Therefore, in the present invention, one or more selected from the above are measurement items.
Among these, the area of the blood vessel, the number of blood vessels, the width or diameter of the blood vessel, the state of branching of the blood vessel, and the rate of blood vessel elongation are easy to measure, and are particularly useful as indicators for grasping the state of angiogenesis. It is considered effective. Accordingly, in a preferred embodiment of the present invention, the number of blood vessels, the area of the blood vessels, the width or diameter of the blood vessels, the state of branching of the blood vessels, and / or the rate of blood vessel expansion are adopted as the measurement items.
In a particularly preferred embodiment of the present invention, the total area of the blood vessel is employed as one of the measurement items.

卵黄心血管系の状態に加えて、胚の状態を観察・測定することにしてもよい。例えば胚の大きさ、胚の組織の状態(目の大きさなど)を測定対象にすることができる。   In addition to the state of the yolk cardiovascular system, the state of the embryo may be observed and measured. For example, the size of the embryo and the state of the embryo's tissue (eye size, etc.) can be measured.

肉眼観察、顕微鏡下での観察、カメラ撮影、ビデオ撮影などによって測定が実施される。具体的には例えば、後述の実施例に示すように、デジタルカメラで一定光度下、卵黄上の任意の場所の血管部分(各々の卵黄における血管系の座標位置は各々について予め定義しておくとよい)を、接写角度90°で、薬剤添加後から経時的に撮影する。   Measurement is performed by visual observation, observation under a microscope, camera photography, video photography, and the like. Specifically, for example, as shown in an example described later, a blood vessel portion at an arbitrary place on the yolk under a constant luminous intensity with a digital camera (the coordinate position of the blood vessel system in each yolk is defined in advance for each of them) Good) is taken over time at a close-up angle of 90 ° after drug addition.

卵黄血管を測定する場合(例えば血管の面積、血管の数などの測定)の測定領域は特に限定されず、殻の一部除去によって露呈している卵表面の一部又は全部を測定領域とする。但し、外部刺激を卵の一部領域のみに与えた場合には、当該領域を測定領域とすること、又は当該領域を測定領域に含めることが好ましい。外部刺激を与えた領域は外部刺激の直接的な作用・影響を受ける領域であり、当該領域を測定対象とすれば外部刺激の作用・影響を高感度に測定できるからである。
外部刺激を与えた領域と測定領域とが異なっていてもよい。また、卵の全体に対して外部刺激を与えた場合(例えば卵の露呈部全体に対して被験物質を添加した場合)、露呈部全体を測定領域としても、露呈部の一部のみを測定領域としてもよい。
When measuring yolk blood vessels (for example, measuring the area of the blood vessels, the number of blood vessels, etc.), the measurement area is not particularly limited, and a part or all of the egg surface exposed by removing a part of the shell is used as the measurement area. . However, when an external stimulus is applied only to a partial region of the egg, it is preferable to set the region as a measurement region or include the region in the measurement region. This is because a region to which an external stimulus is applied is a region that is directly affected / affected by the external stimulus, and the effect / effect of the external stimulus can be measured with high sensitivity if the region is a measurement target.
The region to which the external stimulus is applied may be different from the measurement region. Moreover, when an external stimulus is given to the whole egg (for example, when a test substance is added to the whole exposed part of the egg), even if the whole exposed part is set as the measurement area, only a part of the exposed part is measured. It is good.

本ステップにおける測定を複数の時点で実施してもよい。例えば、ある時点から所定時間、連続して測定する。このような経時的な測定によれば卵黄心血管系の状態をモニターすることができる。従って、外部刺激が卵黄心血管系に及ぼす作用・影響の経時的変化を評価できる。卵黄心血管系を測定対象とする本発明の評価方法の一つの特徴は、同個体(卵)を用いてこのような経時的な測定を行えることである。即ち本発明の評価方法によれば複数の測定時点のデータを同個体から得ることができる。従って、測定時点毎に異なる個体が用いられる評価系において問題とされる、個体差に起因する誤差やデータの信頼性の低下のない評価系となる。   The measurement in this step may be performed at a plurality of times. For example, the measurement is continuously performed for a predetermined time from a certain time point. According to such measurement over time, the state of the yolk cardiovascular system can be monitored. Therefore, it is possible to evaluate changes over time in the action and influence of external stimulation on the yolk cardiovascular system. One feature of the evaluation method of the present invention in which the yolk cardiovascular system is a measurement target is that such time-dependent measurement can be performed using the same individual (egg). That is, according to the evaluation method of the present invention, data at a plurality of measurement points can be obtained from the same individual. Therefore, the evaluation system is free from errors caused by individual differences and a decrease in data reliability, which is a problem in an evaluation system in which different individuals are used for each measurement time point.

4.ステップ(4)
ステップ(4)では、ステップ(3)の測定結果より、外部刺激の卵黄心血管系への作用を評価する。このステップではステップ(3)で得たデータをデータの性質に応じた解析に供する。例えば、デジタルカメラなどによって画像データを得た場合、適当なソフトウエアで画像解析を行う。
4). Step (4)
In step (4), the effect of external stimulation on the yolk cardiovascular system is evaluated from the measurement result of step (3). In this step, the data obtained in step (3) is subjected to analysis according to the nature of the data. For example, when image data is obtained by a digital camera or the like, image analysis is performed using appropriate software.

通常、外部刺激を与えた卵(試験群)より得たデータと、外部刺激を与えないこと以外は同条件とした卵(対照群)より得たデータとを比較することによって外部刺激の作用を評価する。
例えば、測定項目として血管面積(測定領域における血管の総面積)を採用した場合に試験群の測定値が対照群の測定値よりも小さいとき(即ち外部刺激の結果として測定値の減少が認められるとき)、外部刺激(例えば被験物質)に血管新生抑制作用があると判定できる。これとは逆に試験群の測定値が対照群の測定値よりも大きいとき、外部刺激に血管新生促進作用があると判定できる。
同様に、測定項目として血管数を採用した場合では、血管数の増減に基いて被験物質の血管新生に対する作用を判定できる。
ステップ3で経時的測定を実施した場合には、測定結果(データ)の時間的変化量(速度)に基づいて評価してもよい。
Usually, the effects of external stimuli are compared by comparing the data obtained from eggs with external stimuli (test group) and the data obtained from eggs with the same conditions (control group) except that no external stimuli are given. evaluate.
For example, when the blood vessel area (total blood vessel area in the measurement region) is adopted as the measurement item, when the measurement value of the test group is smaller than the measurement value of the control group (that is, a decrease in the measurement value is recognized as a result of external stimulation) ), It can be determined that an external stimulus (for example, a test substance) has an anti-angiogenic effect. On the contrary, when the measured value of the test group is larger than the measured value of the control group, it can be determined that the external stimulus has an angiogenesis promoting action.
Similarly, when the number of blood vessels is employed as the measurement item, the effect of the test substance on angiogenesis can be determined based on the increase or decrease in the number of blood vessels.
When the temporal measurement is performed in step 3, the evaluation may be performed based on the temporal change amount (speed) of the measurement result (data).

<ニワトリ初期胚卵黄心血管系を利用した血管新生の定量>
血管新生は多くの疾患と関係しており、血管新生を調節する方法や薬剤の開発が精力的に行われている。血管新生が関与する疾患として、糖尿病の合併症としての網膜症、炎症性疾患(例えば、リウマチ様関節炎)、高脂血症、腫瘍等がある。血管新生は創傷の治療過程においても重要な役割を果たす。
血管新生は、発生段階における管芽細胞からの全く新しい脈管系の発生と、すでに組織に存在する血管系からの内皮細胞増殖を基本とした新しい血管枝の形成(狭義の血管新生)とに大別される。
<Angiogenesis quantification using early embryonic egg yolk cardiovascular system>
Angiogenesis is associated with many diseases, and methods and drugs for regulating angiogenesis are energetically developed. Diseases involving angiogenesis include retinopathy as a complication of diabetes, inflammatory diseases (for example, rheumatoid arthritis), hyperlipidemia, tumors and the like. Angiogenesis also plays an important role in the wound healing process.
Angiogenesis consists of the development of a completely new vascular system from tuberoblasts at the developmental stage and the formation of new vascular branches based on the proliferation of endothelial cells from the vascular system already present in the tissue (narrow definition angiogenesis). Broadly divided.

ニワトリ初期胚卵黄心血管系を利用した血管新生の定量実験を以下の手順で実施した。尚、図1に実験手順の概要を図解する。
1.転卵培養(孵卵後数日間)
産卵直後の受精卵を温度37.5℃、相対湿度60%の条件下、2.8日間転卵培養した(転卵角度90°で1時間に2回)。
2.卵殻切断と静置培養(孵卵後数日間経過後)
転卵培養後、鈍端部側の卵殻横面円周を切断し、観察用開口部を卵殻上部に設けた。卵表面にリング状のプラスチック小板(内径約5mm)を載せた後、卵表面が乾燥しないように蓋をし、温度37.5℃、相対湿度60%の条件下、静置培養した。
3.静置培養開始から24時間後に、プラスチック小板の中央開口部位置(測定領域)の卵表面にPBSで溶解した薬剤(血管新生阻害剤カプトプリル)を以下の通り添加した。尚、薬剤添加後は静置培養を継続した。
実験区1:5 mg/ml(in PBS)のカプトプリル(アンジオテンシン変換酵素(ACE)阻害剤、シグマ・アルドリッチ社製)を100μl添加
実験区2:0.5 mg/ml(in PBS)のカプトプリルを100μl添加
対照区:PBSを100μl添加
無添加区:添加なし
4.撮影
添加0分後から添加120分後まで10分間隔で測定領域を写真撮影することで(デジタルカメラ)卵黄心血管系の状態を経時的に観察した。
5.画像解析
得られた画像データを次の手順で解析し、測定領域に存在する卵黄血管の総面積を算出した(図2)。
(1)画像データのグレースケール変換
(2)黒点の検出
(3)黒点数と全点数から黒比率の算出
(4)黒比率を血管面積に換算
画像解析結果(血管面積変化率)のグラフを図3に示す。添加60分後から、薬剤添加区(実験区1、実験区2)と、溶媒添加区又は無添加区との間に有意差が認められる(危険率0.5%)。このようにわずか60分という短時間で薬剤の作用を明確に判定可能であった。尚、ニワトリ受精卵の尿漿膜血管系を利用して同様の実験を行えば、結果を得るまでに通常10日以上を要する。その上、血管が多くの場所で重なりあっているので測定データにばらつきが大きくなる。一方、培養細胞を利用した評価系であっても結果を得るまでに通常7日以上を要する。また、測定データは細胞の状態に大きく依存し、信頼性の高い結果を得ることは困難である。
An angiogenesis quantitative experiment using the early chicken embryonic yolk cardiovascular system was carried out by the following procedure. FIG. 1 illustrates the outline of the experimental procedure.
1. Egg culture (several days after incubation)
Fertilized eggs immediately after egg laying were cultured for 2.8 days under conditions of a temperature of 37.5 ° C. and a relative humidity of 60% (twice an hour at an egg turning angle of 90 °).
2. Eggshell cutting and stationary culture (after several days after incubation)
After the turnover culture, the circumference of the eggshell lateral surface on the blunt end side was cut, and an opening for observation was provided in the upper part of the eggshell. After placing a ring-shaped plastic plate (inner diameter of about 5 mm) on the egg surface, the egg was covered with a lid so that the egg surface was not dried, and cultured at a temperature of 37.5 ° C. and a relative humidity of 60%.
3. Twenty-four hours after the start of stationary culture, a drug (angiogenesis inhibitor captopril) dissolved in PBS was added to the egg surface at the central opening position (measurement region) of the plastic platelet as follows. The static culture was continued after the addition of the drug.
Experimental group 1: Add 100 μl of 5 mg / ml (in PBS) captopril (Angiotensin converting enzyme (ACE) inhibitor, Sigma-Aldrich) Experimental group 2: Add 100 μl of 0.5 mg / ml (in PBS) captopril Control group: 100 μl of PBS added No additive group: No addition Photographing The measurement area was photographed at 10-minute intervals from 0 minutes after addition to 120 minutes after addition (digital camera), and the state of the yolk cardiovascular system was observed over time.
5. Image analysis The obtained image data was analyzed by the following procedure, and the total area of yolk blood vessels present in the measurement region was calculated (FIG. 2).
(1) Grayscale conversion of image data
(2) Black spot detection
(3) Calculate black ratio from the number of black spots and the total number of black spots
(4) Convert black ratio to blood vessel area A graph of the image analysis result (blood vessel area change rate) is shown in FIG. From 60 minutes after the addition, a significant difference is observed between the drug addition group (experiment group 1, experiment group 2) and the solvent addition group or the non-addition group (risk rate 0.5%). Thus, the action of the drug could be clearly determined in a short time of only 60 minutes. In addition, if a similar experiment is performed using the urinary serosa vasculature of a chick fertilized egg, it usually takes 10 days or more to obtain a result. In addition, since blood vessels overlap in many places, the measurement data varies greatly. On the other hand, even in an evaluation system using cultured cells, it usually takes 7 days or more to obtain a result. Moreover, the measurement data greatly depends on the state of the cell, and it is difficult to obtain a reliable result.

以上の実験例で明らかなように、卵黄血管を利用した評価方法によれば非常に短時間で評価結果が得られる。従って当該方法はハイスループット化に適した評価系である。   As is clear from the above experimental examples, according to the evaluation method using egg yolk blood vessels, evaluation results can be obtained in a very short time. Therefore, this method is an evaluation system suitable for high throughput.

本発明によれば、薬剤の添加など外部刺激の作用を短時間で評価することが可能である。例えば以下の目的において本発明の評価方法を利用することができる。
(1)薬剤候補の検索、特に血管新生、血管の伸長・肥大等に作用(抑制又は促進)する薬剤候補の検索
(2)被験物質(例えば薬剤)の血管新生、血管の伸長・肥大等に及ぼす影響(毒性、副作用)の評価
(3)細胞又は組織の培養条件として好ましい外部刺激の検索
According to the present invention, it is possible to evaluate the effect of external stimulation such as addition of a drug in a short time. For example, the evaluation method of the present invention can be used for the following purposes.
(1) Search for drug candidates, especially search for drug candidates that act (suppress or promote) angiogenesis, blood vessel elongation, hypertrophy, etc.
(2) Evaluation of the effects (toxicity, side effects) of test substances (for example, drugs) on angiogenesis, blood vessel elongation, hypertrophy, etc.
(3) Search for external stimuli preferred as cell or tissue culture conditions

この発明は、上記発明の実施の形態及び実施例の説明に何ら限定されるものではない。特許請求の範囲の記載を逸脱せず、当業者が容易に想到できる範囲で種々の変形態様もこの発明に含まれる。
本明細書の中で明示した論文、公開特許公報、及び特許公報などの内容は、その全ての内容を援用によって引用することとする。
The present invention is not limited to the description of the embodiments and examples of the invention described above. Various modifications may be included in the present invention as long as those skilled in the art can easily conceive without departing from the description of the scope of claims.
The contents of papers, published patent gazettes, patent gazettes, and the like specified in this specification are incorporated by reference in their entirety.

ニワトリ卵黄心血管系を利用した評価系を示す図である。It is a figure which shows the evaluation system using a chicken egg yolk cardiovascular system. 画像データの解析手順(一例)を示す図である。It is a figure which shows the analysis procedure (an example) of image data. ニワトリ卵黄心血管系を利用した評価系で得られた実験結果のグラフ(血管面積変化率)である。It is a graph (blood vessel area change rate) of the experimental result obtained by the evaluation system using a chicken egg yolk cardiovascular system.

Claims (9)

以下のステップを含む、外部刺激の作用を評価する方法、
(1)鳥類の受精卵を用意するステップ、
(2)前記受精卵に対して被験対象の外部刺激を与えるステップ、
(3)前記受精卵の卵黄心血管系の状態を測定するステップ、
(4)測定結果より、前記外部刺激の卵黄心血管系への作用を評価するステップ。
A method for evaluating the action of an external stimulus, comprising the following steps:
(1) a step of preparing a fertilized egg of a bird,
(2) applying an external stimulus of a test subject to the fertilized egg,
(3) measuring the state of the yolk cardiovascular system of the fertilized egg,
(4) A step of evaluating the effect of the external stimulus on the yolk cardiovascular system from the measurement result.
前記受精卵が胚の発生ステージ15〜22のときにステップ(2)を実施する、請求項1に記載の評価方法。   The evaluation method according to claim 1, wherein step (2) is performed when the fertilized egg is in the embryonic development stage 15-22. 前記受精卵が胚の発生ステージ15〜18のときにステップ(2)を実施する、請求項1に記載の評価方法。   The evaluation method according to claim 1, wherein step (2) is performed when the fertilized egg is in the embryonic development stage 15-18. 尿漿膜血管系が卵黄血管系よりも優勢になる前にステップ(3)を実施する、請求項1〜3のいずれかに記載の評価方法。   The evaluation method according to any one of claims 1 to 3, wherein step (3) is performed before the serous vasculature becomes more dominant than the yolk vasculature. ステップ(3)において、卵黄心血管系の状態を経時的に測定する、請求項1〜4のいずれかに記載の評価方法。   The evaluation method according to any one of claims 1 to 4, wherein in step (3), the state of the yolk cardiovascular system is measured over time. 前記外部刺激が、被験物質の添加、光の照射、電磁波の照射、放射線の照射、音波の照射、電気刺激、振動の付加、及び圧力の付加からなる群より選択される一以上の外部刺激である、請求項1〜5のいずれかに記載の評価方法。   The external stimulus is one or more external stimuli selected from the group consisting of test substance addition, light irradiation, electromagnetic wave irradiation, radiation irradiation, sound wave irradiation, electrical stimulation, vibration addition, and pressure addition. The evaluation method according to any one of claims 1 to 5. 前記卵黄心血管系の状態として、血管の面積、血管の数、血管の幅又は径、血管の枝分かれの状態、血管の伸長速度、血液量、血液の流速、血球移動速度、及び胚の心拍数からなる群より選択される一以上の項目をステップ(3)において測定する、請求項1〜6のいずれかに記載の評価方法。   As the state of the yolk heart vasculature, the area of the blood vessel, the number of blood vessels, the width or diameter of the blood vessel, the state of the branching of the blood vessel, the blood vessel elongation rate, the blood volume, the blood flow rate, the blood cell migration rate, and the heart rate of the embryo The evaluation method according to claim 1, wherein at least one item selected from the group consisting of: is measured in step (3). 前記卵黄心血管系の状態として、血管の面積、血管の数、血管の幅又は径、血管の枝分かれの状態、及び血管の伸長速度からなる群より選択される一以上の項目をステップ(3)において測定する、請求項1〜6のいずれかに記載の評価方法。   Step (3) selected from the group consisting of the area of blood vessels, the number of blood vessels, the width or diameter of blood vessels, the state of branching of blood vessels, and the rate of blood vessel expansion as the state of the yolk heart vasculature The evaluation method according to claim 1, which is measured in step 1. 前記鳥類がニワトリ又はウズラである、請求項1〜8のいずれかに記載の評価方法。   The evaluation method according to claim 1, wherein the birds are chickens or quails.
JP2005089667A 2005-03-25 2005-03-25 Method for evaluating external stimulation Pending JP2006262863A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2005089667A JP2006262863A (en) 2005-03-25 2005-03-25 Method for evaluating external stimulation
PCT/JP2006/305687 WO2006103988A1 (en) 2005-03-25 2006-03-22 Method of evaluating external stimulus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005089667A JP2006262863A (en) 2005-03-25 2005-03-25 Method for evaluating external stimulation

Publications (1)

Publication Number Publication Date
JP2006262863A true JP2006262863A (en) 2006-10-05

Family

ID=37053247

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005089667A Pending JP2006262863A (en) 2005-03-25 2005-03-25 Method for evaluating external stimulation

Country Status (2)

Country Link
JP (1) JP2006262863A (en)
WO (1) WO2006103988A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE922172A1 (en) * 1991-07-06 1993-01-13 Univ Leicester Bioassay method

Also Published As

Publication number Publication date
WO2006103988A1 (en) 2006-10-05

Similar Documents

Publication Publication Date Title
De Luca et al. ZebraBeat: a flexible platform for the analysis of the cardiac rate in zebrafish embryos
Ainge et al. The role of the hippocampus in object recognition in rats: examination of the influence of task parameters and lesion size
Lütcke et al. Optical recording of neuronal activity with a genetically-encoded calcium indicator in anesthetized and freely moving mice
Zhang et al. Ca2+ signaling in human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) from normal and catecholaminergic polymorphic ventricular tachycardia (CPVT)-afflicted subjects
Tessadori et al. Identification and functional characterization of cardiac pacemaker cells in zebrafish
CN104704360B (en) Fowl embryo gender, vigor and/or stage of development determine in egg
JP7187151B2 (en) Method and apparatus for image analysis of living cells
AlMalki et al. Assessment methods for angiogenesis and current approaches for its quantification
Altizer et al. Endogenous electric current is associated with normal development of the vertebrate limb
Benslimane et al. Adaptation of a mice doppler echocardiography platform to measure cardiac flow velocities for embryonic chicken and adult zebrafish
Wagdi et al. Selective optogenetic control of Gq signaling using human Neuropsin
Mahler et al. Cardiac developmental toxicity
Rinaldi et al. HCN1 channels in cerebellar Purkinje cells promote late stages of learning and constrain synaptic inhibition
Canto et al. Postnatal development of functional projections from parasubiculum and presubiculum to medial entorhinal cortex in the rat
Fuss et al. Immediate early gene expression related to learning and retention of a visual discrimination task in bamboo sharks (Chiloscyllium griseum)
Wilcockson et al. An improved Erk biosensor detects oscillatory Erk dynamics driven by mitotic erasure during early development
CN101448952A (en) Method for screening reagent with vascular regulating activity by teleost embryos
Krausova et al. Teratogenic and lethal effects of 2–24 h hyperthermia episodes on chick embryos
EP2115462B1 (en) Method of in vivo screening for cardiac toxic agents using teleost
Smith et al. Real-time monitoring of electrically evoked catecholamine signals in the songbird striatum using in vivo fast-scan cyclic voltammetry
Brito et al. Retrieval of contextual aversive memory and induction of Zenk expression in the hippocampus of pigeons
JP2006262863A (en) Method for evaluating external stimulation
Watanabe et al. Probing the electrophysiology of the developing heart
Vugler et al. Constant illumination causes spatially discrete dopamine depletion in the normal and degenerate retina
Ho et al. A stable proportion of Purkinje cell inputs from parallel fibers are silent during cerebellar maturation